Concepedia

José Bonafont

JB

Statistics

Publications

6

Citations

286

H-Index

6

Active since

2018

Affiliations

Centre for Biomedical Network Research on Rare Diseases(Current)

Hospital Universitario Fundación Jiménez Díaz

Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas

Universidad Carlos III de Madrid

Centro de Investigación Biomédica en Red

José Bonafont is an author at Centre for Biomedical Network Research on Rare Diseases specializing in col7a1 mutations, genome editing, and dystrophic epidermolysis bullosa.

ORCID

Publications per year

2018–2022

6

Publications

6

Clinically Relevant Correction of Recessive Dystrophic Epidermolysis Bullosa by Dual sgRNA CRISPR/Cas9-Mediated Gene Editing

José Bonafont, Ángeles Mencía, Marta García et al. · Molecular Therapy · 2019 · 108 citations · Full text

, , +17

Non-viral delivery of CRISPR–Cas9 complexes for targeted gene editing via a polymer delivery system

Jonathan O’Keeffe Ahern, Irene Lara‐Sáez, Dezhong Zhou et al. · Gene Therapy · 2021 · 67 citations · Full text

, , +17

Deletion of a Pathogenic Mutation-Containing Exon of COL7A1 Allows Clonal Gene Editing Correction of RDEB Patient Epidermal Stem Cells

Ángeles Mencía, Cristina Chamorro, José Bonafont et al. · Molecular Therapy — Nucleic Acids · 2018 · 47 citations · Full text

, , +14

Efficient CRISPR-Cas9-Mediated Gene Ablation in Human Keratinocytes to Recapitulate Genodermatoses: Modeling of Netherton Syndrome

Victoria Gálvez, Esteban Chacón-Solano, José Bonafont et al. · Molecular Therapy — Methods & Clinical Development · 2020 · 22 citations · Full text

, , +16

Mechanistic interrogation of mutation-independent disease modulators of RDEB identifies the small leucine-rich proteoglycan PRELP as a TGF-β antagonist and inhibitor of fibrosis

Esteban Chacón-Solano, Carlos León, Marta Carretero et al. · Matrix Biology · 2022 · 21 citations · Full text

, , +17

1–5 of 6